Technology News Covid 19 Moderna Must Fulfil Its Promise To Share Technology To Ensure Covid 19 Vaccine Breakthrough Is Not Limited To Rich Countries Amnesty International
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Technology News Covid 19 Moderna Must Fulfil Its Promise To Share Technology To Ensure Covid 19 Vaccine Breakthrough Is Not Limited To Rich Countries Amnesty International is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Moderna settles Alnylam patent lawsuits over COVID vaccine technology

Sept 18 (Reuters) - Moderna (MRNA.O), opens new tab has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' (ALNY.O), opens new tab patented technology in its COVID-19 ... Read More
Moderna, Alnylam settle patent row over COVID vaccine delivery technology

Moderna (NASDAQ:MRNA) has agreed to resolve a patent litigation in which Alnylam Pharmaceuticals (NASDAQ:ALNY) has alleged that the delivery technology used in the company’s COVID-19 vaccine has ... Read More
Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for ... Read More
Pfizer, Moderna defend COVID vaccine effectiveness after Trump remarks

Sept 3 (Reuters) - Pfizer (PFE.N), opens new tab and Moderna (MRNA.O), opens new tab on Wednesday defended their COVID-19 vaccines as having saved millions of lives worldwide, in separate responses to ... Read More
Moderna trims top end of full-year forecast on weak COVID vaccine sales

Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of its COVID-19 vaccine in the U.S. as Americans struggled to access the shots. Read More
Moderna's new flu shot shows strong results in older adults

July 1 (UPI) --Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced. The vaccine, called mRNA-1010, ... Read More
Moderna says key study of its CMV vaccine, expected to be its next big win, failed

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus

